<< Back To Article
Enanta’s New NS5A Inhibitor Shows Early Promise Against Hep C

Write a Comment

I have read and agree to the terms and conditions in the Posting Rules*


Zsuzsanna Snarey

I am very hopeful that this drug will be available soon and will not be priced too high for NHS England. A single dose to cure me seems like the perfect answer. I have Hepatitis C genotype 1b and I have mild Fibrosis. F1-2. Fibroscan 8.1 This means that I do not deserve treatment until I develop cirrhosis. This seems very unfair!

October 25, 2015 Sandwich


Hot topics